DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Exhibition & Sponsorship Opportunities
    • Attending Exhibitors and Sponsors
    • The DDL Incubator
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • RDD 2027
  • The Aerosol Society logo
Varsha Nair

Varsha Nair

The University of Texas at Austin

Paper:

Download Paper

My research focus is on overcoming challenges of dose and stability for delivering therapeutics as a dry powder for inhalation. Through the use of different formulation and processing methods, dry powders for inhalation are generated to enable disease targeting in the lungs. This includes inhalation delivery for both small and large molecules for disease areas such as asthma, COPD and bacterial lung infections.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk